Translational Cancer Research Unit

The Translational Cancer Research Unit (TCRU) applies a translational approach to its research activities, collaborating and working across various disciplines of cancer research to improve clinical outcomes for patients by decreasing the incidence of cancer, increasing patient survival rates and improving their quality of life.

In 2011, the group achieved a massive coup after being awarded a $1.8 million grant from the Cancer Institute for their work. The grant will fund the TCRU's three year program which aims to facilitate research and clinical trials in the areas of molecular cancer pathology, radiation and medical oncology, and palliative care, while also having a strong emphasis on developing tissue biobanking.

Other aims of the program are to strengthen the link between cancer services, cancer research and primary care, while also training and mentoring Australia's next generation of cancer researchers.

Group Leader:
Dr Paul de Souza 
View Profile